Evidence map›Paper›PMID 30944006›Full record

ArticleVirology journal2019

Anti-H7N9 avian influenza A virus activity of interferon in pseudostratified human airway epithelium cell cultures.

Ai-Jun Chen, Jie Dong, Xin-Hui Yuan, Hong Bo, Shu-Zhen Li, Chao Wang, Zhao-Jun Duan, Li-Shu Zheng

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ai-Jun ChenNational Institute for Viral Disease Control and Prevention, China CDC, Key Laboratory for Medical Virology National Health Commission, 100 Ying-Xin St., Xi-Cheng District, Beijing, 100052, China.
Jie DongNational Institute for Viral Disease Control and Prevention, China CDC, Key Laboratory for Medical Virology National Health Commission, 100 Ying-Xin St., Xi-Cheng District, Beijing, 100052, China.
Xin-Hui YuanThe First Hospital of Lanzhou University, Lanzhou, 730000, China.
Hong BoNational Institute for Viral Disease Control and Prevention, China CDC, Key Laboratory for Medical Virology National Health Commission, 100 Ying-Xin St., Xi-Cheng District, Beijing, 100052, China.
Shu-Zhen LiNanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Chao WangNational Institute for Viral Disease Control and Prevention, China CDC, Key Laboratory for Medical Virology National Health Commission, 100 Ying-Xin St., Xi-Cheng District, Beijing, 100052, China.
Zhao-Jun DuanNational Institute for Viral Disease Control and Prevention, China CDC, NHC Key Laboratory of Medical Virology and Viral Diseases, 100 Ying-Xin St., Xi-Cheng District, Beijing, 100052, China. zhaojund@126.com.
Li-Shu ZhengNational Institute for Viral Disease Control and Prevention, China CDC, Key Laboratory for Medical Virology National Health Commission, 100 Ying-Xin St., Xi-Cheng District, Beijing, 100052, China. zhenglishu2000@sina.com.ORCID 0000-0002-8780-6191
Chinese Center For Disease Control and Prevention · CNFirst Hospital of Lanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince H7N9 influenza A virus (H7N9) was first reported in 2013, five waves of outbreaks have occurred, posing a huge threat to human health. In preparation for a potential H7N9 epidemic, it is essential to evaluate the efficacy of anti-H7N9 drugs with an appropriate model.

methodsWell-differentiated pseudostratified human airway epithelium (HAE) cells were grown at the air-liquid interface, and the H7N9 cell tropism and cytopathic effect were detected by immunostaining and hematoxylin-eosin (HE) staining. The H7N9 replication kinetics and anti-H7N9 effect of recombinant human α2b (rhIFN-α2b) and rhIFN-λ1 were compared with different cell lines. The H7N9 viral load and interferon-stimulated gene (ISG) expression were quantified by real-time PCR assays.

resultsH7N9 could infect both ciliated and non-ciliated cells within the three-dimensional (3D) HAE cell culture, which reduced the number of cilia and damaged the airways. The H7N9 replication kinetics differed between traditional cells and 3D HAE cells. Interferon had antiviral activity against H7N9 and alleviated epithelial cell lesions; the antiviral activity of rhIFN-α2b was slightly better than that of rhIFN-λ1. In normal cells, rhIFN-α2b induced a greater amount of ISG expression (MX1, OAS1, IFITM3, and ISG15) compared with rhIFN-λ1, but in 3D HAE cells, this trend was reversed.

conclusionsBoth rhIFN-α2b and rhIFN-λ1 had antiviral activity against H7N9, and this protection was related to the induction of ISGs. The 3D cell culture model is suitable for evaluating interferon antiviral activity because it can demonstrate realistic in vivo-like effects.

Indexed as

Viral TropismAntiviral AgentsCell LineCytokinesEpithelial CellsHumansInfluenza A Virus, H7N9 SubtypeInterferon alpha-2Interferon LambdaInterferonsInterleukinsLungMembrane ProteinsMyxovirus Resistance ProteinsRNA-Binding ProteinsUbiquitinsAntiviral AgentsCytokinesIFITM3 protein, humanInterferon alpha-2Interferon Lambdainterferon-lambda, humanInterferonsInterleukinsISG15 protein, humanMembrane ProteinsMX1 protein, humanMyxovirus Resistance ProteinsRNA-Binding ProteinsUbiquitinsAvian influenza A virusH7N9Human airway epitheliumInterferonInterferon-stimulated genes

Identifiers

PMID30944006
PMCPMC6448296
OpenAlexW2942849842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.